Unlocking the mystery of preexisting drug resistance: Study sheds light on cancer evolution
The evolution of resistance to diseases, from infectious illnesses to cancers, poses a formidable challenge.
Jul 15, 2024
0
19
The evolution of resistance to diseases, from infectious illnesses to cancers, poses a formidable challenge.
Jul 15, 2024
0
19
Immunotherapy can be a highly effective treatment for non-small cell lung cancer (NSCLC), but some patients are resistant to the therapy or develop intolerable side effects.
Jul 12, 2024
0
59
The World Health Organization's cancer agency on Friday classified talc as "probably carcinogenic" for humans, however an outside expert warned against misinterpreting the announcement as a "smoking gun".
Jul 5, 2024
0
67
Twelve years ago, cancer researchers at University of California San Diego identified a molecule that helps cancer cells survive by shuttling damaging inflammatory cells into tumor tissue. In new research, they show that ...
Jul 3, 2024
0
5
Neuroendocrine tumors, including small cell lung cancer and neuroendocrine prostate cancer, are very aggressive with high chances of spreading. However, many individuals develop resistance to few available treatment options, ...
Jul 3, 2024
0
13
A new imaging technique developed at Memorial Sloan Kettering Cancer Center (MSK) shows promise for detecting deadly forms of lung cancer and prostate cancer. The technology uses a radioactive particle that binds to a ligand ...
Jul 1, 2024
0
14
Researchers at Brigham and Women's Hospital have developed a new nanomedicine therapy that delivers anticancer drugs to lung cancer cells and enhances the immune system's ability to fight cancer.
Jun 14, 2024
0
70
The reason targeted treatment for non-small cell lung cancer fails to work for some patients, particularly those who have never smoked, has been discovered by researchers from UCL, the Francis Crick Institute and AstraZeneca.
Jun 13, 2024
0
81
Researchers at Columbia University College of Dental Medicine have developed an exosome-based platform, "safeEXO-Cas," that significantly enhances the delivery of CRISPR/Cas9 genome editing components to specific cells and ...
Jun 7, 2024
0
160
In a recent study led by Suresh Ramalingam, MD, executive director of Winship Cancer Institute of Emory University, a new drug has shown remarkable promise in treating patients with a specific type of advanced lung cancer.
Jun 5, 2024
0
19